Verition Fund Management’s Inari Medical, Inc. Common Stock NARI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-48,490
Closed -$2.48M 3810
2024
Q4
$2.48M Buy
48,490
+18,555
+62% +$912K 0.01% 1415
2024
Q3
$1.23M Buy
+29,935
New +$1.44M 0.01% 1740
2023
Q4
Sell
-6,598
Closed -$432K 2741
2023
Q3
$432K Buy
+6,598
New +$415K 0.01% 1526
2023
Q2
Sell
-11,350
Closed -$701K 2615
2023
Q1
$701K Buy
11,350
+8,108
+250% +$486K 0.01% 1084
2022
Q4
$206K Buy
+3,242
New +$235K ﹤0.01% 1743
2022
Q2
Sell
-78,600
Closed -$7.12M 3181
2022
Q1
$7.12M Buy
+78,600
New +$6.43M 0.09% 241
2021
Q4
Sell
-36,972
Closed -$3M 2853
2021
Q3
$3M Buy
36,972
+26,712
+260% +$2.24M 0.03% 437
2021
Q2
$957K Buy
10,260
+7,802
+317% +$756K 0.01% 825
2021
Q1
$263K Buy
+2,458
New +$255K ﹤0.01% 1186

Other funds holding NARI

Verition Fund Management's NARI Position: Q1 2025 in Review

Verition Fund Management sold out of Inari Medical, Inc. Common Stock (NARI) in Q1 2025, closing a stake of 48,490 shares — an estimated $2.48M sold.

Verition Fund Management first reported a position in NARI in Q1 2021 and held it in 9 quarters. The position peaked at $7.12M in Q1 2022. 4 funds tracked by Wall St. Rank hold NARI as of Q1 2025.

  • Verition Fund Management reported no remaining Inari Medical, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • Verition Fund Management sold 48,490 Inari Medical, Inc. Common Stock shares in Q1 2025, an estimated $2.48M.
  • Verition Fund Management first reported a position in Inari Medical, Inc. Common Stock in Q1 2021 and held it in 9 quarters.
  • Verition Fund Management's Inari Medical, Inc. Common Stock position peaked at $7.12M in Q1 2022.
  • 4 funds tracked by Wall St. Rank held Inari Medical, Inc. Common Stock as of Q1 2025.

Based on Verition Fund Management's 13F filing for Q1 2025, filed 15 May 2025.